Friedl-Naderer Johanna Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
2
Insider Sells Sum
$35,552.40

Insider Activity of Friedl-Naderer Johanna

According to the SEC Form 4 filings, Friedl-Naderer Johanna, being in a position of

  1. Chief Commercial Officer at Dyne Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 891 share for $17,972,
    over all time since 2025-03-13, has bought 0 shares, and sold 2218 shares for $35,449.

Biography of Friedl-Naderer Johanna

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $17,9725100

Comparison of Insiders on Amount of Buys and Sells

2026-08-13SaleDyne Therapeutics, Inc.
DYN
Chief Commercial Officer
226
0.0001%
$26.28$5,939-34.09%
2026-06-16SaleDyne Therapeutics, Inc.
DYN
Chief Commercial Officer
145
<0.0001%
$18.33$2,658+17.65%
2026-05-13SaleDyne Therapeutics, Inc.
DYN
Chief Commercial Officer
228
0.0001%
$18.36$4,186+1.3%
2026-03-05SaleDyne Therapeutics, Inc.
DYN
Chief Commercial Officer
148
<0.0001%
$14.90$2,205+21.15%
2025-12-05SaleDyne Therapeutics, Inc.
DYN
Chief Commercial Officer
144
0.0001%
$20.72$2,984-10.11%
2025-09-05SaleDyne Therapeutics, Inc.
DYN
Chief Commercial Officer
144
<0.0001%
$13.41$1,931+29.82%
2025-09-04SaleDyne Therapeutics, Inc.
DYN
Chief Commercial Officer
894
0.0006%
$13.27$11,863+39.35%
2025-06-05SaleDyne Therapeutics, Inc.
DYN
Chief Commercial Officer
146
0.0001%
$13.35$1,949+22.37%
2025-03-13SaleDyne Therapeutics, Inc.
DYN
Chief Commercial Officer
143
0.0001%
$12.12$1,733+12.88%
2023-03-03SaleVir Biotechnology, Inc.
VIR
EVP & Chief Operating Officer
1,482
0.0011%
$22.82$33,819-45.73%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.